SI
NAVB

SII Investments’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

SII Investments’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,551
Closed -$30K – 625
2017
Q3 		$30K Hold
3,551
– – ﹤0.01% 596
2017
Q2 		$37K Sell
3,551
-965
-21% -$9.54K ﹤0.01% 590
2017
Q1 		$52K Hold
4,516
– – ﹤0.01% 602
2016
Q4 		$55K Hold
4,516
– – ﹤0.01% 584
2016
Q3 		$82K Buy
4,516
+965
+27% +$12.2K 0.01% 577
2016
Q2 		$38K Sell
3,551
-965
-21% -$19K ﹤0.01% 577
2016
Q1 		$86K Buy
4,516
+965
+27% +$18.6K 0.01% 553
2015
Q4 		$95K Sell
3,551
-965
-21% -$33.5K 0.01% 439
2015
Q3 		$205K Buy
4,516
+1,115
+33% +$42K 0.02% 490
2015
Q2 		$109K Hold
3,401
– – 0.01% 503
2015
Q1 		$109K Sell
3,401
-5
-0.1% -$169 0.01% 512
2014
Q4 		$128K Buy
3,406
+250
+8% +$6.88K 0.02% 484
2014
Q3 		$83K Buy
3,156
+150
+5% +$3.97K 0.01% 488
2014
Q2 		$89K Hold
3,006
– – 0.01% 463
2014
Q1 		$102K Hold
3,006
– – 0.02% 409
2013
Q4 		$125K Buy
+3,006
New +$118K 0.02% 415
2013
Q3 		– Sell
-2,521
Closed -$134K – 405
2013
Q2 		$134K Buy
+2,521
New +$126K 0.03% 359

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SII Investments's NAVB Position: Q4 2017 in Review

SII Investments sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2017, closing a stake of 3,551 shares — an estimated $30K sold.

SII Investments first reported a position in NAVB in Q2 2013 and held it in 17 quarters. The position peaked at $205K in Q3 2015. 54 funds tracked by Wall St. Rank hold NAVB as of Q4 2017.

  • SII Investments reported no remaining Navidea Biopharmaceuticals Inc. position as of Q4 2017 after selling out during the quarter.
  • SII Investments sold 3,551 Navidea Biopharmaceuticals Inc. shares in Q4 2017, an estimated $30K.
  • SII Investments first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 17 quarters.
  • SII Investments's Navidea Biopharmaceuticals Inc. position peaked at $205K in Q3 2015.
  • 54 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2017.

Based on SII Investments's 13F filing for Q4 2017, filed 9 Feb 2018.